# ALX Oncology Holdings Inc: Form 8-K, filed Apr 25, 2025

- Company: [ALX Oncology Holdings Inc](/companies/alxo.md) (CIK 1810182)
- Form: 8-K
- Filed: 2025-04-25
- Accepted by EDGAR: Apr 25, 2025, 20:01 ET
- Period: 2025-04-23
- Accession: 0000950170-25-058687
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1810182/000095017025058687/alxo-20250423.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1810182/000095017025058687/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1810182/000095017025058687/alxo-20250423.htm

Filed Apr 25, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-058687. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.